Immunohistochemical expression of cycloxygenase-2 in astrocytoma: Correlation with angiogenesis, tumor progression and survival;Astrositomalarda siklooksijenaz 2'nin i̇mmünohistokimyasal ekspresyonu ve bu ekspresyonun angiogenesis, tümör yayılımı ve saǧ-kalım ile olan i̇lişkisi

Turkish Neurosurgery

Volumn 21, Issue 1, 2011, Pages 27-35

  El Sayed, Mona ^a   Taha, Mahmoud M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Angiogenesis; Astrocytoma; COX 2; VEGF

Indexed keywords

EID: 79751499605     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Robert M, Lawrence WD, Munkarah AR: The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Cancer 98: 1423-1429, 2003.
2. Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56: 1106-1111, 1985.
3. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerrer BM, Mosferrer JL, Dannenberg AJ: Cyclooxygenase -2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991-994, 1999.
4. Davies G, Salter J, Hills M, Martin LA, Sacks N, Dowsett M. Yang HY, Yang L: Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res 9: 2651-2656, 2003.
5. Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R: Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol (Berl) 98: 240-244, 1999.
6. Ding Y, Chen G, Xia J, Zang XW: Association of VCAM-1overexpression with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 9 (7): 1409-1414, 2003.
7. DuBois RN, Abramson SB, Crofford L, Gupta R, Simon L, Van De Pantle L, Lipsky PC, Faseb J: Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
8. DuBois RN, Awad J, Morrow J, Roberts LJ, Bishop PR: Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor- and phorbol ester. J Clin Investig 93: 493-498, 1994.
9. Fujimoto M, Fults DW, Thomas GA, Nakamura Y, Heilbrun MP, White R, Story JL, Naylors L, Kagan-Hallet KS, Sheridan PJ: Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4: 210-214, 1989.
10. Fujiwaki R, Lida K, Kawasaki H, Ozaki T, Hata K, Miyazaki K: Cyclooxygenase-2 expression in endometrial cancer: Correlation with micro-vessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Human Pathol 33:213-219, 2002.
11. Gallo O, Masini E, Bianchi B, Brushini L, Paglerani M, Franchi A: Prognostic significance of cyclo-oxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Human Pathol 33:708-714, 2002.
12. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86: 353-356, 1996.
13. Hara A, Okayasu I: Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 108: 43-48, 2004.
14. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft S, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM: Expression of cyclooxygenase-2 in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60: 4926-4931, 2000.
15. Joo YE, Rew JS, Seo YH, Choi SK, Kim YJ, Park CS, Kim SJ: Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol 37: 28-33, 2003.
16. Kang HC, Xu F, Liu XY, Hu Q, Liu Y, Tang K, Li X, Wang Y, Liu ZG, Zhu SQ: Brain injury in adenosine A1 receptor knock-out mice after pentetrazole kindling and its correlation with COX-2. Zhonghua Yi Xue Za Zhi 89(37):2634-2638, 2009.
17. Kieser A, Weich H, Brandner G: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9:963-969, 1994.
18. Kleihues P, Cavenee WK: Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000:29-39.
19. Kujubu DA., Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266: 12866-12872, 1991.
20. Lee JM, Jung S, Rhu HH, Kim IY, Lee MC: Cyclooxygenase-2 expression predicts Prognosis in astrocytic tumors. J Korean Neurosurg Soc 36: 437-442, 2004.
21. Majima M, Amano H, Hayashi I: Angiogenic and prostaglandin. Folia Pharmacol Jpn 117:283-292, 2001.
22. Marina P, Penelope K, Irene T: Cyclooxygenase-2 expression in astrocytomas. Relationship with micro-vascular parameters, angiogenetic factors expression and survival. J Molecular and Cellular Biochemistry 295: 75-83, 2007.
23. Miettinen S, Fusco F R, Yrjanheikki J, Keinanen R, Hirvonen T, Roivainen R, Narthi M, Hokfelt T, Koistinaho J: Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phosphor-lipase A2. Proc Natl Acad Sci USA 94: 6500-6505, 1997.
24. Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H: Expression of cyclooxygenase-2 in renal cell carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin. Cancer Res 9: 1741-1749, 2003.
25. Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA: Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal antiinflammatory drugs. Cancer Res 59: 4356-4362, 1999.
26. Murakami H, Sawa H, Kamada H: Expression of cyclooxygenase (COX)-2 in astrocytic tumors and antitumor effects of selective COX-2 inhibitors. Brain Nerve 58:43-49 (Abstract), 2006.
27. Onguru O, Gamsizkan M, Ulutin C, Gunhan O: Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma. Neuropathology 28: 29-34, 2008.
28. Pairet M, Engelhardt G: Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications. Fundam Clin Pharmacol 10: 1-17, 1996.
29. Perdiki M, Korkolopoulou P, Thymara I, Agrogiannis G, Piperi C, Boviatsis E, Kotsiakis X, Angelidakis D, Diamantopoulou K, Thomas-Tsagli E, Patsouris E: Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. Mol Cell Biochem 295 (1-2): 75-83, 2007.
30. Rasheed BK, Fuller GN, Friedman AH, Bigner DD, Bigner SH: Loss of heterozygosity for 10q loci in human gliomas. Genes chromosomes. Cancer 5: 75-82, 1992.
31. Sairanen T, Ristimaki A, Karjalainen-Lindsberg ML, Paetau A, Kaste M, Lindsberg PJ: Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 43: 738-747, 1998.
32. Samaras V, Piperi C, Levidou G, Zisakis A, Kavantzas N, Themistocleous MS, Boviatsis EI, Barbatis C, Lea RW, Kalofoutis A, Korkolopoulou P: Analysis of interleukin (IL)-8 expression in human astrocytomas: Associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry. Human Immunol 70(6):391-397, 2009.
33. Sawada T: Angiogenic factor of brain tumor. No-Shinkei 51: 404-410, 1999.
34. Sawaoka H, Tsuji S, Tsuji M, Edhi S, Sasaki Y, Kawano S, Hori M: Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 79:1469-1478, 1999.
35. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF: Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations. Cancer Res 61:4375-4381, 2001.
36. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ: Inhibition of cyclo-oxygenase-2 gene expression by p53. J Biol Chem 274: 10911-10915, 1999.
37. Takekawa Y, Sawada T, Sakurai I: Neovascular basement membrane and its significance in the biological behavior of astrocytic tumors. Neuropathology 17:196-200, 1997.
38. Taketo MM: Cyclo-oxygenase-2 nhibitors in tumorigenesis (part I). J Natl Cancer Inst (Bethesda) 90: 1529-1536, 1998.
39. Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois R: Cyclooxygenase regulates angio-genesis induced by colon cancer cells. Cell 93:705-716, 1998.
40. Von Deimling A, Louis DN, von Ammon K, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeild DA, Yasargil MG, Wiestler OD, et al: Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 295-301, 1992.
41. Wardlaw SA, March TH, Belinsky SA: Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis (Lon) 21: 1371-1377, 2000.
42. Yamin R, tong-yu C: Expression and significance of HIFa, COX-2 and VEGF proteins in glioma. Modern oncology 14 (2): (Abstract), 2006.
43. Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ: Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (Lon) 21: 139-146, 2000.
44. Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Charqui J, Yoshimura N, Hla T, Wada s: Expression of cyclooxygenase-2 in prostate carcinoma. Cancer (Phila) 89: 589-596, 2000.
45. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert H E, Schror K: Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59: 198-204, 1999.